NCT06945848View on ClinicalTrials.gov

Venous Stenting Evaluation in Patients With Intracranial Hypertension Under Long-term Acetazolamide

NANot yet recruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

October 30, 2028

Study Completion Date

April 30, 2029

Conditions
Idiopathic Intracranial Hypertension (IIH)
Interventions
DRUG

Acetazolamide

Acetazolamide will be maintained and weight loss will be recommended

DEVICE

Stent (Tentos 4F or Precise ProRX)

Transverse venous sinus will be stented by neuroradiological intervention

Trial Locations (3)

31000

CHU de Toulouse, Toulouse

34295

CHU de Montpellier Hôpital Gui de Chauliac, Montpellier

51092

CHU de Reims, Reims

All Listed Sponsors
collaborator

Direction Générale de l'Offre de Soins

OTHER_GOV

lead

University Hospital, Montpellier

OTHER

NCT06945848 - Venous Stenting Evaluation in Patients With Intracranial Hypertension Under Long-term Acetazolamide | Biotech Hunter | Biotech Hunter